Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 22607854)

Published in Am Heart J on May 01, 2012

Authors

Matthew J Crowley1, Benjamin J Powers, Evan R Myers, Amanda J McBroom, Gillian D Sanders

Author Affiliations

1: Duke Evidence-Based Practice Center, Duke Clinical Research Institute, Durham, NC, USA. matthew.crowley@dm.duke.edu

Articles by these authors

Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med (2007) 7.31

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09

Non-evidence-based ICD implantations in the United States. JAMA (2011) 5.05

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20

Improving patient care. The patient centered medical home. A Systematic Review. Ann Intern Med (2012) 3.90

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol (2012) 3.51

Effect of clinical decision-support systems: a systematic review. Ann Intern Med (2012) 3.42

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ (2010) 3.41

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15

Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med (2009) 3.13

Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol (2009) 3.08

Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol (2006) 3.08

Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril (2004) 3.03

Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Arch Intern Med (2008) 2.96

An economic evaluation of prolonged mechanical ventilation. Crit Care Med (2007) 2.93

Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med (2003) 2.72

The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis (2003) 2.72

Absence of secretory endometrium after false-positive home urine luteinizing hormone testing. Fertil Steril (2004) 2.59

Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol (2005) 2.50

Acute myocardial infarction in pregnancy: a United States population-based study. Circulation (2006) 2.49

Evaluating human papillomavirus vaccination programs. Emerg Infect Dis (2004) 2.47

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42

Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050. Am J Obstet Gynecol (2011) 2.36

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22

Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev (2013) 2.18

Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet Gynecol (2013) 2.17

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine (2008) 2.09

The intersection of patient complexity, prescriber continuity and acute care utilization. J Gen Intern Med (2014) 1.90

Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 1.90

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA (2003) 1.89

Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med (2011) 1.80

Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. Ann Intern Med (2005) 1.69

Enabling health care decisionmaking through clinical decision support and knowledge management. Evid Rep Technol Assess (Full Rep) (2012) 1.68

Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med (2014) 1.67

Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. J Gen Intern Med (2008) 1.67

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin (2009) 1.66

Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information. J Gen Intern Med (2011) 1.62

Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med (2003) 1.61

Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator. Health Aff (Millwood) (2005) 1.60

Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol (2008) 1.59

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst (2006) 1.58

Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Obstet Gynecol (2013) 1.56

The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril (2006) 1.56

Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction. Cancer (2010) 1.53

FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol (2005) 1.52

Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis. Cardiol J (2011) 1.50

Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol (2008) 1.49

Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia. AIDS (2006) 1.48

Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol (2011) 1.47

Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis. Am J Med (2004) 1.44

Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med (2007) 1.44

Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer. Gynecol Oncol (2011) 1.44

Do the benefits of participation in a hypertension self-management trial persist after patients resume usual care? Circ Cardiovasc Qual Outcomes (2014) 1.42

HPV vaccines: now that they're here, how do we maximize their benefit? Contraception (2006) 1.41

ECG-based signal analysis technologies for evaluating patients with acute coronary syndrome: a systematic review. J Electrocardiol (2012) 1.39

Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer. Obstet Gynecol (2010) 1.31

Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey. Fertil Steril (2008) 1.30

Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab (2010) 1.29

Effect of hysterectomy with ovarian preservation on ovarian function. Obstet Gynecol (2011) 1.28

Abnormal outcomes following cervical cancer screening: event duration and health utility loss. Med Decis Making (2007) 1.28

The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol (2005) 1.22

Adherence to nicotine replacement therapy among pregnant smokers. Nicotine Tob Res (2009) 1.21

Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol (2009) 1.19

Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. Am J Respir Crit Care Med (2009) 1.16

Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene. J Clin Endocrinol Metab (2007) 1.14

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis. Cost Eff Resour Alloc (2008) 1.14

Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment. Gynecol Oncol (2009) 1.12

Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol (2009) 1.10

Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV. Am J Public Health (2007) 1.10

Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09

Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it? Gynecol Oncol (2008) 1.09

Management of adnexal mass. Evid Rep Technol Assess (Full Rep) (2006) 1.08

Evaluating cough assessment tools: a systematic review. Chest (2013) 1.07

Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens (2009) 1.07

Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence. J Urol (2009) 1.06

Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care (2003) 1.06

HIV testing of at risk patients in a large integrated health care system. J Gen Intern Med (2007) 1.03

Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J (2005) 1.01

Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J (2008) 1.01

Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. Nicotine Tob Res (2006) 1.01

Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends. Am J Obstet Gynecol (2011) 1.00

Patient self-management support: novel strategies in hypertension and heart disease. Cardiol Clin (2010) 1.00

Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis (2010) 0.99

Projecting the need for gynecologic oncologists for the next 40 years. Obstet Gynecol (2010) 0.99

Evidence-based practice for mere mortals: the role of informatics and health services research. J Gen Intern Med (2002) 0.98

Should older women have antepartum testing to prevent unexplained stillbirth? Obstet Gynecol (2004) 0.97

Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race? Ann Noninvasive Electrocardiol (2011) 0.96

Cost-effectiveness analysis of annual screening strategies for endometrial cancer. Am J Obstet Gynecol (2009) 0.96